key: cord-0289242-8igplkhf
authors: Gallagher, Catriona; Mahon, Julie Mac; O’Neill, Chloe; Cassidy, Féaron C.; Dunbar, Hazel; De Barra, Conor; Cadden, Caoimhe; Pisarska, Marta M.; Wood, Nicole; Masterson, Joanne C.; McNamee, Eoin N.; English, Karen; O’Shea, Donal; Tobin, Anne Marie; Hogan, Andrew E.
title: Mucosal associated invariant T cells are altered in patients with Hidradenitis Suppurativa and contribute to the inflammatory milieu
date: 2022-01-18
journal: bioRxiv
DOI: 10.1101/2022.01.17.476587
sha: 36fc54a7fb0149300f19ef7dc46dc0b3b364b5a6
doc_id: 289242
cord_uid: 8igplkhf

Mucosal Associated Invariant T cells are a population of “innate” T cells, which express the invariant T cell receptor (TCR) α chain Vα 7.2-Jα 33 and are capable of robust rapid cytokine secretion, producing a milieu of cytokines including IFN-γ and IL-17. MAIT cells have been reported in multiple human tissues including the gut, periphery and skin. On-going research has highlighted their involvement in numerous inflammatory diseases ranging from rheumatoid arthritis and obesity to psoriasis. Hidradenitis Suppurativa (H.S) is a chronic inflammatory disease of the hair follicles, resulting in painful lesions of apocrine-bearing skin. Several inflammatory cytokines have been implicated in the pathogenesis of H.S including IL-17. The role of MAIT cells in H.S is currently unknown. In this study we show for the first time, that MAIT cells are altered in the peripheral blood of patients with H.S, with reduced frequencies and an IL-17 cytokine bias. We show that CCL20 expression is elevated in lesions of patients with H.S, and MAIT cells can actively traffic towards lesions via CCL20. We show that MAIT cells can accumulate in the lesions from patients with H.S. when compared to adjacent skin, with an IL-17 bias. We show that elevated IL-17, can be linked to the activation of dermal fibroblasts, promoting the expression of chemotactic signals including CCL20 and CXCL1. Finally, we show that targeting the IL-17A transcription factor RORyt robustly reduces IL-17 production by MAIT cells from patients with H.S. Collectively our data details IL-17 producing MAIT cells as a novel player in the pathogenesis of H.S and highlights the potential of RORyt inhibition as a novel therapeutic strategy.

Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition which affects up to 4% of the population, resulting in the development of nodules and abscesses in apocrine-bearing skin of the axillae, groin, buttocks and the inframammary fold (1, 2) .

Hidradenitis suppurativa impacts significantly on the patient's quality of life and emotional well-being (3) (4) (5) . The pathogenesis of H.S is still not fully understood but emerging evidence has highlighted significant immune dysregulation and inflammation as key drivers of the disease (6) . Inflammatory cytokines such as TNF-alpha, IL-1beta and IL-17 have all been identified as possible contributors to H.S (7) (8) (9) (10) . This is supported by the clinical responsiveness to TNF-alpha inhibitors, corticosteroids and immunosuppressive agents (11) (12) (13) (14) . However, only a proportion of patients respond to these, thus a deeper understanding of the players and mechanisms underpinning the disease are required. Several immune cell populations have been identified in the lesions of H.S patients, including macrophages, neutrophils, natural killer cells, CD1a-myeloid cells and CD4+ T cells (7, (15) (16) (17) .

MAIT cells are a population of non-MHC restricted innate T cells that are important in the immune defense against bacterial and viral infections (18) . MAIT cells are early responding T cells that are capable of rapidly producing multiple cytokines upon activation such as IFN-gamma, TNF-alpha and IL-17 (19) . MAIT cells are activated when their invariant TCR recognize bacterial derivatives presented on the MHC like molecule MR1 (20) . MAIT cells can also be activated in a T cell receptor independent manner, via cytokine stimulation(21). Dysregulated MAIT cell cytokine profiles have been reported in several chronic inflammatory diseases including obesity and arthritis (22) (23) (24) (25) . Recent studies have identified altered MAIT cells in the skin of psoriasis patients, with an increased frequency of IL-17 producing MAIT cells found in the psoriatic lesion but not healthy skin(26). The authors conclude that MAIT cells are an additional source of IL-17 in psoriatic skin that may be contributing to the disease. MAIT cells have also been implicated in the pathogenesis of dermatitis herpetiformis, a clinical manifestation of gluten hypersensitivity. Frequencies of these cells appear to be significantly increased in this skin disease compared with healthy controls(27). The mechanism is still relatively unknown, however much like psoriasis, IL-17 has been associated with dermatitis herpetiformis pathogenesis(28). To date MAIT cells have not been studied in the context of H.S and were the focus of this study. We show that MAIT cells are altered in the periphery of patients with H.S, with reduced frequencies and elevated production of IL-17. We demonstrate that MAIT cells can traffic via CCL20, the expression of which is elevated in H.S lesions. In the lesions of patients with H.S we observed increased frequencies of IL-17 producing MAIT cells when compared to adjacent skin. Using a cell-based model we show that IL-17 can drive the expression of CCL20 and CXCL1 by dermal fibroblasts, which may support the accumulation of inflammatory T cells and neutrophils in the lesion. Finally, we demonstrate that targeting of RORgt using a small molecule inhibitor limits the production of IL-17 by MAIT cells.

A cohort of 20 adults with hidradenitis suppurativa were enrolled into this study after providing informed consent, along with an aged & sex matched cohort of healthy controls (Table 1) . Exclusion criteria included patients with active or recent infections or co-morbid inflammatory conditions outside of H.S. Patients who were on anti-inflammatory medications were also excluded.

cytometric analysis. PBMC were isolated from fresh venous blood samples by density centrifugation. Intradermal immune cells (IDCs) were isolated from 6mm punch biopsies of skin. Briefly, biopsies were minced finely with dissection scissors and mixed with 3mL of digestion buffer (0.8mg/mL collagenase type 4 (Worthington) and 0.02mg/mL DNase I (Sigma-Aldrich) in complete RPMI culture media containing 10% FBS). Samples were incubated overnight in 5% CO2 before washing through a 100um filter with culture media. CD45 staining was used to identify the immune fraction.

MAIT cell staining (1 x10 6 PBMC) was performed using specific surface monoclonal antibodies (All Miltenyi Biotec) namely; CD3, CD161, CD8, CCR6, PD-1, CD69 and Matched adjacent skin biopsies were used as controls. After 18 hours media was harvested and investigated for expression of CCL20 by ELISA (R&D systems).

Interleukin-2 expanded MAIT cells (1x10 6 ) from healthy donors were also cultured in the TCM (both control and lesion) for 18 hours with or without TCR Dynabeads Data is expressed as SEM. We determined differences between two groups using student t-test or Mann Whitney U test where appropriate. Analysis across 3 or more groups was performed using ANOVA. P values were expressed with significance set at <0.05.

James Hospital Joint Research and Ethics Committee. All patients gave written informed consent prior to partaking in the study.

suppurativa and display an IL-17 bias. We first investigated the frequencies of MAIT cells in the peripheral blood of patients with hidradenitis suppurativa (PWHS), MAIT cells were identified as CD3 + , TCR Va7.2 + and CD161 HI after doublet discrimination ( Figure 1A ). We noted no difference in the percentage of total CD3 + T cells between PWHS and controls ( Figure 1B ). However, we did observe a significant reduction in MAIT cell frequencies in the peripheral blood of PWHS when compared to healthy controls ( Figure 1C ). We next investigated the activation status of MAIT cells in the peripheral blood PWHS and noted no difference in the expression of CD69, a common T cell activation marker ( Figure 1D ), but did observe an increase in the expression of the late activation/exhaustion marker PD-1 compared to controls ( Figure 1E ). Finally, we examined the cytokine production profile and note increased production of IL-17 ( Figure 1F ) and in parallel decreased IFNg production ( Figure 1G ).

a CCR6-CCL20 axis. With the observation of reduced MAIT cell frequencies in the peripheral blood of PWHS, we next asked, could MAIT cells be trafficking towards lesions.

We first measured the tissue homing chemokine receptor CCR6 expression on MAIT cells from both PWHS and controls and observed no difference in either frequency or intensity ( Figure 2A -C). We next measured the levels of CCL20, the chemokine which binds CCR6, in lesions from PWHS and adjacent skin, and observed increased expression of both CCL20 mRNA and protein in lesions when compared to adjacent skin ( Figure 2D-E) .

Finally, using a transwell system, we investigated if MAIT cells could migrate towards either recombinant CCL20 or tissue conditioned media, and demonstrate that MAIT cells actively traffic towards both CCL20 and lesion conditioned media ( Figure 2F -G).

Having demonstrated that MAIT cells could migrate towards lesions from PWHS, we next investigated if they were present in lesions from PWHS. The CD3 + T cell compartment in skin was identified within the CD45 + population, with MAIT cells identified as previously described ( Figure 3A ). We observed a significant accumulation of MAIT cells in hidradenitis suppurativa lesions compared to matched adjacent skin ( Figure 3B -C). Next, we investigated the cytokine profiles of MAIT cells in lesions, demonstrating an increase in MAIT cells producing IL-17 compared to adjacent skin with comparable levels of IFNg ( Figure 3D-F) . Finally, we investigated the impact of HS lesion conditioned media on the IL-17 production of healthy MAIT cells and it can drive elevated IL-17 production ( Figure   3G ). (8, 16) . We show that IL-17 can alter dermal fibroblasts resulting in elevated CCL20 and CXCL1 expression, both of which have been reported to be increased in PWHS (9, 38) . The elevated expression of these cytokines supports the significant immune infiltration reported in PWHS including accumulation of neutrophils and T cells (16, 39, 40) . In a recent case study, targeting IL-17 with secukinumab resulted in significant improvements in hidradenitis suppurativa severity (14) highlighting not only a role for IL-17 in disease pathogenesis but a potential therapeutic target. Retinoic acid receptor-related-gt (RORgt) is the key transcription factor in IL-17 producing T cells (41) . 

Scatter plots displaying the mRNA expression of Col1A, MMP1, CXCL1 or CCL20 in dermal fibroblasts stimulated with IL-17 (20ng/ml) for 24 hours. Data is representative of minimum 2 independent experiments. Significant differences are indicated by *(p<0.05), **(p<0.01) and ***(p<0.001). 

Hidradenitis suppurativa: a comprehensive review

Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States

Quality of life impairment in hidradenitis suppurativa: a study of 61 cases

Psychophysical aspects of hidradenitis suppurativa

Profound consequences of hidradenitis suppurativa: a review

Hidradenitis suppurativa: the role of immune dysregulation

Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa

Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

Treatments for hidradenitis suppurativa

Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors

A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa

Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study

Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with Ctype lectin receptor

Mucosal-associated invariant T cells and disease

Obesity Reduces mTORC1 Activity in Mucosal-Associated Invariant T Cells, Driving Defective Metabolic and Functional Responses

Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells

Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients

The biology and functional importance of MAIT cells

Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity

Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients